Jun 9, 2020
Aalto Bio Reagents Ltd. a leading developer of critical raw materials and reagents for the development of diagnostic tests, globally announced today that its Sars-CoV-2 n-s1-S2 antigens, Lysis buffers and Viral transport media are part of assays that are being run in Europe and the U.S. on the screening front line for detection of COVID-19 with production estimates in the tens of millions of COVID-19 antibody tests per month.
From the start of this COVID-19 pandemic in January, Aalto Bio has supported over 50 global diagnostic companies and vaccine developers to build tests for COVID-19 with critical raw materials for the CV-19 virus detection which has enabled front-line testing using multiples of millions of diagnostic tests. In February 2020, Aalto Bio began offering its first neucleocapsid COVID-19 protein soon after the Wuhan strain of the virus came on stream. In April, this was followed by our new COVID-19 Lysis buffer reagent for pre-treating COVID-19 samples prior to testing and then in late April our Viral transport media to transport COVID-19 samples. The early availability of our COVID 19 proteins has helped diagnostic manufacturers and vaccine developers alike build high-quality assays with our critical raw materials to faster determine the clinical status of COVID-19.
“Aalto Bio Reagents Ltd. remains on hand to help our diagnostic manufacturing partners around the globe meet their COVID-19 diagnostic testing requirements, as we have done since the outset of this world health crisis by delivering first-in-class critical raw material products during this pandemic. We will continue to offer ourselves to help innovate diagnostic testing to faster diagnose this virus," stated Philip Noone CEO Aalto Bio.
About Aalto Bio Reagents
Founded in 1978, Aalto Bio Reagents is a leading developer and provider of raw materials to the in-vitro diagnostics industry and to research laboratories globally. We serve the largest multinational companies in our industry with a broad range of purified human proteins; monoclonal and polyclonal antibodies; fungal, parasitic, bacterial and viral antigens; and disease state plasma for in-vitro diagnostic application. Since the company's inception, we have built strong working relationships with our clients who trust us to provide them with the highest quality raw materials to meet the exacting standards of their own product development requirements. Headquartered in Dublin, Ireland, the company is rapidly expanding both its product portfolio and customer base. For further information please visit http://www.aaltobioreagents.com
Contact: Aalto Bio Tel: +353-1-4900685 Email: [email protected]
In French Guiana, the fight against illegal gold mining is rapidly being lost and creating an environmental and health disaster, according to the World Wildlife Fund. During an aerial survey in early August, park rangers counted 239 illegal sites within the protected area in record.
Love you, but HOW do you not own a pack of compression bags yet...? View Entire Post ›
"They put ours to shame." View Entire Post ›
Because there are one too many holiday movies that start with the main character missing a flight, and that does NOT need to be your journey this season. View Entire Post ›
In the first instalment of a four-part Health Matters series on food and health, Lisa Cam unpacks the enduring ritual of Cantonese soup, revealing what modern science says about family recipes, seasonal ingredients and the modern workarounds keeping this domestic staple on the table. In many Chinese households, soups are seen as a show of love from the cook – usually the matriarch of the family. Soup can be everyday food or a banquet course made with ingredients according to the season. The...
More than 80 million people worldwide stutter, yet misconceptions on it persist in the medical field, and access to appropriate care can be limited. New international medical guidelines aim to change that.
Canada is spending more on health care than ever. Whether Canadians are getting more care for their money is another question. A new report from the Canadian Institute for Health Information (CIHI) projects health-care spending will reach a record $433 billion in 2026, or $10,398 per person, an increase of 4.8 per cent over last year.
Dozens of international flights departed from the United States during Friday’s nationwide ground stop. Some planes also left for Hawaii from the West Coast.
And now, Take 2: the new Met Gala exhibition will celebrate everyday garments and materials such as jeans and puffer jackets, paper and plastic – and how fashion designers transform them. The new theme sounds about as far as can be imagined from the glittering, elaborate designs of John Galliano, the British designer who was originally the subject of the Met’s fashion exhibition next spring – before that idea was scuttled amid an outcry over his past antisemitic statements. The replacement show...
Following the opening of Brasserie Europe at Le Plaza in June, the cultural destination is now gearing up to open Cinéma-Hôtel Le Plaza on 04 December 2026, marking a major milestone for the project. This will then be followed by the opening of the reimagined historic Plaza Centre Cinéma on 22 April 2027, completing the transformation of this iconic architectural landmark.
Portugal has been high on the wish list of Rail Europe’s travel trade partners for some time. Now, with Comboios de Portugal (CP) integrated into its B2B platform, agents can book Portuguese rail services through the same channels they already use for other European train journeys.
TUI is adding five hotels to its TUI BLUE portfolio for UK customers in Croatia, Madeira and Egypt, across summer 2027 and summer 2028. TUI BLUE Diane in Croatia and TUI BLUE Calheta Beach in Madeira join for summer 2027. In Egypt, TUI BLUE Vistamar and TUI BLUE Makadi Oasis also join in summer 2027, with TUI BLUE Palace Sharm following in summer 2028.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.